FDA Abortion Drug Rules Under Fire | Lawrence News

A Virginia federal judge has ordered the FDA to redo its controversial 2023 restrictions on a key abortion medication, calling the agency’s justification “insufficient” and sending the case back for review. The ruling, joined by a similar decision in Hawaii, challenges the FDA’s requirement for special pharmacy certifications, clinician approvals, and mandatory risk acknowledgment forms — all of which abortion providers say add unnecessary bureaucracy and harm patient care. With anti-abortion groups pushing for even stricter controls in states where abortion remains legal, this legal tug-of-war could reshape access to reproductive healthcare across the country. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8f00395b91d741f2